| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
72,962 |
55,149 |
$2.72M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,234 |
8,048 |
$708K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,046 |
7,862 |
$652K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13,656 |
12,588 |
$617K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,643 |
8,999 |
$512K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,745 |
4,661 |
$447K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,490 |
5,018 |
$424K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
29,826 |
13,744 |
$325K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,495 |
11,098 |
$317K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,774 |
13,900 |
$214K |
| 99000 |
|
17,584 |
15,547 |
$178K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,576 |
1,551 |
$138K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15,684 |
13,624 |
$109K |
| S8301 |
Infection control supplies, not otherwise specified |
15,275 |
13,453 |
$101K |
| 99381 |
|
1,248 |
1,185 |
$94K |
| 99383 |
|
751 |
743 |
$70K |
| 99429 |
|
4,024 |
3,930 |
$57K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
550 |
528 |
$49K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,954 |
1,898 |
$45K |
| 92551 |
|
12,576 |
12,251 |
$41K |
| 99384 |
|
400 |
396 |
$41K |
| 99382 |
|
440 |
431 |
$40K |
| 87807 |
|
2,870 |
2,646 |
$32K |
| 83655 |
|
7,575 |
7,460 |
$28K |
| 90461 |
|
11,478 |
6,868 |
$27K |
| 97169 |
|
1,260 |
1,233 |
$22K |
| 92587 |
|
4,717 |
4,630 |
$13K |
| 80053 |
Comprehensive metabolic panel |
8,894 |
8,692 |
$13K |
| 86328 |
|
270 |
262 |
$12K |
| S8101 |
Holding chamber or spacer for use with an inhaler or nebulizer; with mask |
719 |
695 |
$12K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,459 |
1,007 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
743 |
715 |
$11K |
| 69210 |
|
287 |
252 |
$10K |
| 97802 |
|
14,129 |
13,160 |
$9K |
| 96160 |
|
13,906 |
12,985 |
$7K |
| 90734 |
|
1,789 |
1,755 |
$6K |
| 0071A |
|
137 |
132 |
$5K |
| 81002 |
|
1,554 |
1,437 |
$4K |
| S9441 |
Asthma education, non-physician provider, per session |
222 |
217 |
$4K |
| 80061 |
Lipid panel |
4,412 |
4,364 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
636 |
619 |
$4K |
| 0001A |
|
105 |
101 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,138 |
4,090 |
$3K |
| 96116 |
|
47 |
44 |
$3K |
| 85018 |
|
10,596 |
10,453 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
174 |
138 |
$2K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
799 |
765 |
$2K |
| 90474 |
|
293 |
288 |
$2K |
| 99001 |
|
211 |
172 |
$1K |
| 90651 |
|
900 |
878 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
16 |
$901.67 |
| 90619 |
|
57 |
57 |
$888.77 |
| 84030 |
|
1,175 |
999 |
$724.78 |
| 90670 |
|
3,036 |
2,987 |
$714.66 |
| 58301 |
|
34 |
34 |
$700.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
957 |
927 |
$671.98 |
| 0072A |
|
17 |
17 |
$600.00 |
| 0002A |
|
15 |
15 |
$560.00 |
| 90658 |
|
951 |
929 |
$545.35 |
| 90710 |
|
1,669 |
1,629 |
$541.22 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
1,084 |
878 |
$525.00 |
| 99402 |
|
66 |
65 |
$448.24 |
| 90686 |
|
737 |
732 |
$340.01 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$307.98 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,181 |
1,172 |
$235.42 |
| 90688 |
|
414 |
414 |
$206.11 |
| 83525 |
|
2,120 |
2,108 |
$201.76 |
| 90716 |
|
970 |
951 |
$165.25 |
| 90473 |
|
161 |
161 |
$142.64 |
| 90715 |
|
1,223 |
1,207 |
$142.60 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
14,900 |
13,530 |
$105.00 |
| 90723 |
|
979 |
951 |
$100.83 |
| 90633 |
|
2,716 |
2,671 |
$81.32 |
| 94760 |
|
824 |
786 |
$79.03 |
| 90696 |
|
1,427 |
1,395 |
$65.11 |
| 84466 |
|
25 |
25 |
$60.96 |
| 90672 |
|
109 |
109 |
$58.24 |
| A9150 |
Non-prescription drugs |
54 |
53 |
$55.01 |
| 90673 |
|
24 |
24 |
$35.00 |
| 83021 |
|
13 |
13 |
$30.34 |
| 97804 |
|
157 |
154 |
$27.78 |
| 82728 |
|
13 |
13 |
$22.90 |
| 90707 |
|
957 |
939 |
$20.04 |
| 90648 |
|
2,084 |
2,042 |
$19.74 |
| 84443 |
Thyroid stimulating hormone (TSH) |
27 |
27 |
$12.00 |
| 83540 |
|
13 |
13 |
$10.86 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
29 |
26 |
$7.84 |
| J7612 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
507 |
481 |
$6.71 |
| 90677 |
|
1,088 |
1,040 |
$3.54 |
| 90656 |
|
157 |
157 |
$2.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
22 |
12 |
$2.12 |
| 90697 |
|
1,552 |
1,507 |
$1.69 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
23 |
22 |
$0.63 |
| 90621 |
|
513 |
501 |
$0.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$0.14 |
| 3078F |
|
14,542 |
11,697 |
$0.01 |
| 3008F |
|
24,370 |
18,106 |
$0.01 |
| 3074F |
|
13,060 |
10,597 |
$0.01 |
| 91300 |
|
142 |
138 |
$0.00 |
| 99173 |
|
15,453 |
15,085 |
$0.00 |
| 90700 |
|
1,126 |
1,108 |
$0.00 |
| M1005 |
Tb screening not performed or results not interpreted, reason not given |
483 |
483 |
$0.00 |
| 94664 |
|
23 |
23 |
$0.00 |
| 3077F |
|
90 |
83 |
$0.00 |
| 99188 |
|
73 |
71 |
$0.00 |
| 99401 |
|
16 |
16 |
$0.00 |
| 90698 |
|
202 |
200 |
$0.00 |
| 3075F |
|
1,577 |
1,444 |
$0.00 |
| 90680 |
|
2,395 |
2,324 |
$0.00 |
| 2023F |
|
2,587 |
2,511 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
14,375 |
12,979 |
$0.00 |
| 91307 |
|
187 |
181 |
$0.00 |
| 90744 |
|
133 |
132 |
$0.00 |
| 96127 |
|
86 |
84 |
$0.00 |
| 90647 |
|
33 |
33 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
100 |
98 |
$0.00 |
| 90657 |
|
208 |
202 |
$0.00 |
| 90660 |
|
22 |
20 |
$0.00 |
| 3080F |
|
26 |
26 |
$0.00 |
| 3079F |
|
16 |
15 |
$0.00 |